Scienture posts revised investor presentation

Q: What did Scienture Holdings, Inc. (SCNX) announce in this 8-K filing?

Scienture Holdings, Inc. announced that it posted a revised investor presentation on its website on September 14, 2026 and attached it as Exhibit 99.1. The company plans to use this presentation in meetings with analysts, potential investors, and other interested parties.

Q: How is the new Scienture Holdings (SCNX) investor presentation treated under SEC rules?

The investor presentation attached as Exhibit 99.1 is furnished under Item 7.01 of Form 8-K and is not deemed “filed” for purposes of Section 18 of the Exchange Act or automatically incorporated into Securities Act or Exchange Act filings.

Q: Does the Scienture Holdings (SCNX) 8-K include forward-looking statements?

Yes. The company states that the presentation includes forward-looking statements about its projects, potential financial performance, and growth opportunities, and it cautions that actual results may differ materially due to risks discussed in its Form 10-K for the year ended December 31, 2025 and subsequent Form 10-Q filings.

Scienture Holdings furnished an 8-K under Regulation FD to share a revised investor presentation, which is posted online and attached as Exhibit 99.1.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

Scienture Holdings, Inc. (SCNX) furnished a current report to announce that on September 14, 2026 it posted a revised investor presentation on its website, which it plans to use in meetings with analysts, potential investors, and other interested parties. The presentation is attached as Exhibit 99.1 and is treated as furnished, not filed under securities laws, limiting its exposure to certain Exchange Act liabilities and incorporation by reference. The company notes that the presentation contains forward-looking statements and directs readers to risk discussions in its Annual Report on Form 10-K for the year ended December 31, 2025 and subsequent Quarterly Reports on Form 10-Q.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

Filing date: September 14, 2026 Par value per common share: $0.00001 per share Most recent Form 10-K year end referenced: December 31, 2025

3 metrics

Filing date September 14, 2026 Date the company posted and furnished the revised investor presentation

Par value per common share $0.00001 per share Par value of Scienture Holdings, Inc. common stock

Most recent Form 10-K year end referenced December 31, 2025 Year end of the Annual Report cited for risk factors

Key Terms

Regulation FD Disclosure, forward-looking statements, Emerging growth company, Annual Report on Form 10-K, +1 more

5 terms

Regulation FD Disclosure regulatory

"Item 7.01. Regulation FD Disclosure."

Regulation FD disclosure requires public companies to share important, market-moving information with everyone at the same time instead of tipping off analysts or large investors first. Think of it as making sure all players on a field hear the same announcement simultaneously; that fairness helps investors trust that stock prices reflect the same information and reduces the risk of sudden, unfair trading advantages or regulatory penalties for selective leaks.

forward-looking statements regulatory

"The Presentation contains forward-looking statements within the meaning"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

Emerging growth company regulatory

"Emerging growth company"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

Annual Report on Form 10-K regulatory

"in the Company’s Annual Report on Form 10-K for the year ending"

An annual report on Form 10‑K is a required, comprehensive filing that publicly traded companies give to regulators and investors summarizing their business, results of operations, detailed financial statements reviewed by independent auditors, material risks, legal issues and management’s discussion of performance. Investors use it like a company’s year‑end report card and medical checkup: it reveals how the business made money, where it is vulnerable, and the facts needed to compare value, judge risk and make informed investment decisions.

Inline XBRL technical

"Cover Page Interactive Data File (embedded with the Inline XBRL document)"

Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Scienture Holdings, Inc. (SCNX) announce in this 8-K filing?

Scienture Holdings, Inc. announced that it posted a revised investor presentation on its website on September 14, 2026 and attached it as Exhibit 99.1. The company plans to use this presentation in meetings with analysts, potential investors, and other interested parties.

How is the new Scienture Holdings (SCNX) investor presentation treated under SEC rules?

The investor presentation attached as Exhibit 99.1 is furnished under Item 7.01 of Form 8-K and is not deemed “filed” for purposes of Section 18 of the Exchange Act or automatically incorporated into Securities Act or Exchange Act filings.

Where can investors access the revised Scienture Holdings (SCNX) investor presentation?

Investors can access the revised investor presentation, dated September 14, 2026, on the company’s website at www.scientureholdings.com, and it is also included in the 8-K as Exhibit 99.1 to the report.

Does the Scienture Holdings (SCNX) 8-K include forward-looking statements?

Yes. The company states that the presentation includes forward-looking statements about its projects, potential financial performance, and growth opportunities, and it cautions that actual results may differ materially due to risks discussed in its Form 10-K for the year ended December 31, 2025 and subsequent Form 10-Q filings.

What risk disclosures does Scienture Holdings (SCNX) reference in connection with this presentation?

The company refers readers to risk discussions in its SEC filings, including an extensive section in its Annual Report on Form 10-K for the year ended December 31, 2025 and its subsequent Quarterly Reports on Form 10-Q.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 09/14/2026 - 04:06 PM Accepted by SEC EDGAR 09/14/2026 - 04:05 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 14, 2026

SCIENTURE HOLDINGS, INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware

001-39199

46-3673928

(State or other jurisdiction

of incorporation)

(Commission

File No.)

(I.R.S. Employer

Identification No.)

20 Austin Blvd.

Commack, NY 11725

(Address of Principal Executive Offices)

(631) 670-6039

(Registrant’s Telephone Number)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common stock, par value $0.00001 per share		SCNX		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01. Regulation FD Disclosure.

On September 14, 2026, Scienture Holdings, Inc. (the “Company”) posted a revised investor presentation (the “Presentation”) to its website at www.scientureholdings.com. The Company intends to present at various meetings with analysts, potential investors, and other interested parties. A copy of the Presentation is attached hereto as Exhibit 99.1 and incorporated into this Item 7.01 by reference.

The information included in the Presentation is summary information that should be considered in the context of the Company’s filings with the Securities and Exchange Commission (the “SEC”) and other public announcements the Company has made or may make by press release or otherwise from time to time. The Presentation speaks as of the date of this Current Report on Form 8-K (this “Current Report”). While the Company may elect to update the Presentation in the future to reflect events and circumstances that occur or exist after the date of this Current Report, the Company expressly disclaims any obligation to do so.

The information in this Item 7.01, including Exhibit 99.1, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to liabilities under that section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filings, except as shall be expressly set forth by specific reference in such a filing. This Current Report will not be deemed an admission as to the materiality of any information of the information in this Item 7.01, including Exhibit 99.1.

The Presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. With the exception of historical matters, the matters discussed in the press releases include forward-looking statements within the meaning of applicable securities laws. Such forward-looking statements include, among others, statements regarding the Company’s projects, potential financial performance, and growth opportunities. The words “believes,” “expects,” “intends,” “plans,” “anticipates,” “hopes,” “likely,” “will,” and similar expressions are intended to identify certain of these forward-looking statements. These statements are based on the Company’s expectations and involve risks, uncertainties and other important factors that could cause the actual results performance or achievements of the Company (or entities in which the Company has interests), or industry results, to differ materially from future results, performance or achievements expressed or implied by such forward-looking statements. Certain factors that could cause the Company’s actual future results to differ materially from those discussed are noted in connection with such statements, but other unanticipated factors could arise. Certain risks regarding the Company’s forward-looking statements are discussed in the Company’s filings with the SEC, including an extensive discussion of these risks in the Company’s Annual Report on Form 10-K for the year ending December 31, 2025, as amended, and subsequent Quarterly Reports on Form 10-Q filed. Readers are cautioned not to place undue reliance on these forward-looking statements which reflect management’s view only as of the date of this Current Report. The Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, conditions or circumstances.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
99.1		Revised Investor Presentation
104		Cover Page Interactive Data File (embedded with the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.